| Epidemiology and costs of chronic obstructive pulmonary disease KR Chapman, DM Mannino, JB Soriano, PA Vermeire, AS Buist, MJ Thun, ... European Respiratory Journal 27 (1), 188-207, 2006 | 974 | 2006 |
| Tiotropium in combination with placebo, salmeterol, or fluticasone–salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial SD Aaron, KL Vandemheen, D Fergusson, F Maltais, J Bourbeau, ... Annals of internal medicine 146 (8), 545-555, 2007 | 904 | 2007 |
| Indacaterol–glycopyrronium versus salmeterol–fluticasone for COPD JA Wedzicha, D Banerji, KR Chapman, J Vestbo, N Roche, RT Ayers, ... New England Journal of Medicine 374 (23), 2222-2234, 2016 | 823 | 2016 |
| Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. PE Silkoff, PA McClean, AS Slutsky, HG Furlott, E Hoffstein, S Wakita, ... American journal of respiratory and critical care medicine 155 (1), 260-267, 1997 | 532 | 1997 |
| Effect of low concentrations of ozone on inhaled allergen responses in asthmatic subjects NA Molfino, SC Wright, I Katz, S Tarlo, F Silverman, PA McClean, ... The Lancet 338 (8761), 199-203, 1991 | 472 | 1991 |
| Gender bias in the diagnosis of COPD KR Chapman, DP Tashkin, DJ Pye Chest 119 (6), 1691-1695, 2001 | 455 | 2001 |
| Upper airway morphology in patients with idiopathic obstructive sleep apnea J Rivlin, V Hoffstein, J Kalbfleisch, W McNicholas, N Zamel, AC Bryan American Review of Respiratory Disease 129 (3), 355-360, 1984 | 454 | 1984 |
| Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response. LP Boulet, KR Chapman, J Cote, S Kalra, R Bhagat, VA Swystun, ... American journal of respiratory and critical care medicine 155 (6), 1835-1840, 1997 | 430 | 1997 |
| Exhaled nitric oxide in pulmonary diseases: a comprehensive review PJ Barnes, RA Dweik, AF Gelb, PG Gibson, SC George, H Grasemann, ... Chest 138 (3), 682-692, 2010 | 424 | 2010 |
| Benefit of atrial pacing in sleep apnea syndrome S Garrigue, P Bordier, P Jaďs, DC Shah, M Hocini, C Raherison, ... New England Journal of Medicine 346 (6), 404-412, 2002 | 423 | 2002 |
| Suboptimal asthma control: prevalence, detection and consequences in general practice KR Chapman, LP Boulet, RM Rea, E Franssen European Respiratory Journal 31 (2), 320-325, 2008 | 418 | 2008 |
| Pharyngeal size in snorers, nonsnorers, and patients with obstructive sleep apnea TD Bradley, IG Brown, RF Grossman, N Zamel, D Martinez, EA Phillipson, ... New England Journal of Medicine 315 (21), 1327-1331, 1986 | 411 | 1986 |
| Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome TD Bradley, R Rutherford, RF Grossman, F Lue, N Zamel, H Moldofsky, ... American Review of Respiratory Disease 131 (6), 835-839, 1985 | 408 | 1985 |
| Obstructive apneas during sleep in patients with seasonal allergic rhinitis WT McNicholas, S Tarlo, P Cole, N Zamel, R Rutherford, D Griffin, ... American Review of Respiratory Disease 126 (4), 625-628, 1982 | 389 | 1982 |
| Do Patients with Obstructive Sleep Apnea Have Thick Necks? 1, 2 I Katz, J Stradling, AS Swtsky, N Zamel, V Hoffstein Am Rev Respir Dis 141, 1228-1231, 1990 | 381 | 1990 |
| Lung volume dependence of pharyngeal cross-sectional area in patients with obstructive sleep apnea V Hoffstein, N Zamel, EA Phillipson American Review of Respiratory Disease 130 (2), 175-178, 1984 | 381 | 1984 |
| Airflow limitation in morbidly obese, nonsmoking men I Rubinstein, N Zamel, L DuBarry, V Hoffstein Annals of internal Medicine 112 (11), 828-832, 1990 | 347 | 1990 |
| Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials NA Hanania, P Korenblat, KR Chapman, ED Bateman, P Kopecky, ... The Lancet Respiratory Medicine 4 (10), 781-796, 2016 | 340 | 2016 |
| Medical personnel's knowledge of and ability to use inhaling devices: metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers NA Hanania, R Wittman, S Kesten, KR Chapman Chest 105 (1), 111-116, 1994 | 338 | 1994 |
| Minimal clinically important differences in pharmacological trials PW Jones, KM Beeh, KR Chapman, M Decramer, DA Mahler, ... American journal of respiratory and critical care medicine 189 (3), 250-255, 2014 | 335 | 2014 |
Slutsky, ASSt. Michael's HospitalGeverifieerd e-mailadres voor utoronto.ca
